会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 2. 发明申请
    • Composition and method for delivery of biologically-active factors
    • 用于递送生物活性因子的组合物和方法
    • US20040213760A1
    • 2004-10-28
    • US10672144
    • 2003-09-26
    • Lawrence TamarkinGiulio F. Paciotti
    • A61K038/16A61K038/19A61K038/20A61K033/38A61K038/21
    • A61K39/39A61K2039/55505A61K2039/55516A61K2039/55522C07K16/241C07K2317/77
    • In accordance with the present invention, a composition and method is provided that allows for the administration of a biologically-active factors to a human or animal. The present invention can be used to treat a disease with a biologically-active factor or combination of biologically-active factors, or can be used to safely vaccinate a human or animal against a biologically-active factor. It can also be used as a method for the delivery of biologically-active factors for the treatment of disease. Additionally, the present invention also includes a method of targeted drug delivery for the treatment of disease through the administration of custom complexes containing of one or more biologically active factors bound to a colloidal metal where at least one of the biologically-active factors is capable of binding a high affinity receptor on a cell surface.
    • 根据本发明,提供了允许向人或动物施用生物活性因子的组合物和方法。 本发明可用于治疗具有生物活性因子或生物活性因子组合的疾病,或可用于安全地针对生物活性因子对人或动物进行疫苗接种。 它也可以用作递送用于治疗疾病的生物活性因子的方法。 此外,本发明还包括通过施用含有结合到胶体金属的一种或多种生物活性因子的定制复合物来治疗疾病的靶向药物递送的方法,其中至少一种生物活性因子能够 在细胞表面上结合高亲和力受体。
    • 6. 发明申请
    • Alginate containing antimicrobial composition
    • 含有海藻酸盐的抗微生物组合物
    • US20040081706A1
    • 2004-04-29
    • US10425411
    • 2003-04-29
    • Eilidh TrainerThomas Gilchrist
    • A61K033/38A61K033/06A61K031/729
    • A61L26/0095A61L26/0023C08L5/04
    • There is provided a composition comprising an admixture of a finely divided alginate (or a salt or derivative thereof) together with a finely divided carrier material. The composition overcomes the problems associated with applying gel-forming alginates to a body surface without formation of a clumpy paste that leads to local irritation. An admixture of sodium alginate and a water-soluble glass carrier material is preferred. Optionally, the alginate and carrier material each have a particle size of less than 150 nullm diameter and are present in a weight ration of 20:30 to 80:20. The presence of the carrier aids even gel formation and also promotes wound healing.
    • 提供了一种组合物,其包含细分散的藻酸盐(或其盐或衍生物)与细分散的载体材料的混合物。 该组合物克服了将凝胶形成藻酸盐施用于身体表面而不形成导致局部刺激的团块状糊剂的问题。 优选藻酸钠和水溶性玻璃载体材料的混合物。 任选地,藻酸盐和载体材料各自具有小于150μm直径的粒度,并且以20:30至80:20的重量比进行存在。 载体的存在有助于甚至形成凝胶并且还促进伤口愈合。